Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab-Reference-Cited by-同舟云学术

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

Published:2018-07-16 Issue:1 Volume:6 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Capone Mariaelena,Giannarelli Diana,Mallardo Domenico,Madonna Gabriele,Festino Lucia,Grimaldi Antonio Maria,Vanella Vito,Simeone Ester,Paone Miriam,Palmieri Giuseppe,Cavalcanti Ernesta,Caracò Corrado,Ascierto Paolo Antonio^ORCID

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-018-0383-1.pdf

Reference28 articles.

1. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12:252–64.

2. Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015;27:450–61.

3. Weber JS, D'Angelo SP, Minor D, Hodi FS, Gutzmer R, Neyns B, et al. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial. Lancet Oncol. 2015;16:375–84.

4. Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med. 2015;372:320–30.

5. Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, et al. Combined Nivolumab and Ipilimumab or monotherapy in untreated melanoma. N Engl J Med. 2015;373:23–34.

Cited by 333 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation-related markers and prognosis of alpha-fetoprotein producing gastric cancer;World Journal of Gastrointestinal Oncology;2024-09-15

2. Systemic immune-inflammation and prognostic immune nutritional index in oral squamous cell carcinoma patients;Biomarkers in Medicine;2024-09-13

3. Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models;Journal of Clinical Investigation;2024-09-03

4. Prediction of programmed death-1 expression status in non–small cell lung cancer based on intratumoural and peritumoral computed tomography (CT) radiomics nomogram;Clinical Radiology;2024-09

5. Changes in systemic immune-inflammation index (SII) predict the prognosis of patients with hepatitis B-related hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors;Clinical and Translational Oncology;2024-08-17